Imperial College London

ProfessorDavidCarling

Faculty of MedicineInstitute of Clinical Sciences

Professor of Biochemistry
 
 
 
//

Contact

 

+44 (0)20 3313 4313david.carling

 
 
//

Location

 

3rd Fl CRBHammersmith HospitalHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Carling:2017:10.1016/j.ceb.2017.01.005,
author = {Carling, D},
doi = {10.1016/j.ceb.2017.01.005},
journal = {Current Opinion in Cell Biology},
pages = {31--37},
title = {AMPK signalling in health and disease},
url = {http://dx.doi.org/10.1016/j.ceb.2017.01.005},
volume = {45},
year = {2017}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - In eukaryotic cells AMP-activated protein kinase (AMPK) plays a major role in regulating cellular energy balance. AMPK responds to changes in intracellular adenine nucleotide levels, being activated by an increase in AMP/ADP relative to ATP. Activation of AMPK increases the rate of catabolic (ATP-generating) pathways and decreases the rate of anabolic (ATP-utilising) pathways. In addition to its role in maintaining intracellular energy balance, AMPK regulates whole body energy metabolism. Given its key role in controlling energy homeostasis, AMPK has attracted widespread interest as a potential therapeutic target for metabolic diseases, including type 2 diabetes and, more recently, cancer. Here I review the regulation of AMPK and its potential as a target for therapeutic intervention in human disease.
AU - Carling,D
DO - 10.1016/j.ceb.2017.01.005
EP - 37
PY - 2017///
SN - 1879-0410
SP - 31
TI - AMPK signalling in health and disease
T2 - Current Opinion in Cell Biology
UR - http://dx.doi.org/10.1016/j.ceb.2017.01.005
UR - http://www.ncbi.nlm.nih.gov/pubmed/28232179
UR - http://hdl.handle.net/10044/1/45767
VL - 45
ER -